118 related articles for article (PubMed ID: 24813034)
1. Paraoxonase 1 activity and lipid profile in schizophrenic patients.
Mabrouk H; Mechria H; Mechri A; Azizi I; Neffati F; Douki W; Gaha L; Najjar MF
Asian J Psychiatr; 2014 Jun; 9():36-40. PubMed ID: 24813034
[TBL] [Abstract][Full Text] [Related]
2. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
[TBL] [Abstract][Full Text] [Related]
3. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
[TBL] [Abstract][Full Text] [Related]
4. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
7. Lower paraoxonase 1 activity in Tunisian bipolar I patients.
Ezzaher A; Mouhamed DH; Mechri A; Araoud M; Neffati F; Douki W; Gaha L; Najjar MF
Ann Gen Psychiatry; 2010 Oct; 9():36. PubMed ID: 20964824
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
[TBL] [Abstract][Full Text] [Related]
9. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
11. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
[TBL] [Abstract][Full Text] [Related]
13. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.
Apostolou F; Gazi IF; Lagos K; Tellis CC; Tselepis AD; Liberopoulos EN; Elisaf M
Atherosclerosis; 2010 Oct; 212(2):607-13. PubMed ID: 20594556
[TBL] [Abstract][Full Text] [Related]
14. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
[TBL] [Abstract][Full Text] [Related]
15. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
16. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
17. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
18. The correlation of the total antioxidant status (TAS), total oxidant status (TOS) and paraoxonase activity (PON1) with smoking.
Aslan R; Kutlu R; Civi S; Tasyurek E
Clin Biochem; 2014 Apr; 47(6):393-7. PubMed ID: 24440837
[TBL] [Abstract][Full Text] [Related]
19. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
20. Lipid profile in schizophrenia: case control study.
Mhalla A; Bel Hadj Salah W; Mensi R; Amamou B; Messaoud A; Gassab L; Douki W; Najjar MF; Gaha L
Tunis Med; 2018 Jan; 96(1):22-29. PubMed ID: 30324988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
